You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -38.0% | -26.7% |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -3.3 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 1.2 | 0.9 |
Price / Book value | 0.4 |
Latest | Forecast | |
---|---|---|
Revenue | -11.1% | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2018-03-31 | 13.55 | -6.91 | -0.37p | -36.9 | 0.0 | n/a | n/a | 0.0% |
2019-03-31 | 9.76 | 1.18 | -0.09p | -132.5 | 0.0 | n/a | n/a | 0.0% |
2020-03-31 | 9.82 | -8.30 | -0.19p | -38.1 | 0.0 | n/a | n/a | 0.0% |
2021-03-31 | 8.73 | -3.54 | -0.94p | -80.5 | 0.0 | n/a | n/a | 0.0% |
Omega Diagnostics FY revenues surge, sees 'minimal' ongoing Covid income Sharecast News | 07 Apr |
---|---|
Omega's professional-use Covid test rejected by UK regulator Sharecast News | 11 Mar |
Omega selling Scotland factory after government Covid test plans collapse Sharecast News | 11 Feb |
Confirmation of Preliminary Results | 08-Aug-22 07:00 |
---|---|
Holding(s) in Company | 05-Aug-22 12:10 |
Completion of Sale of the CD4 Business | 03-Aug-22 07:00 |
Payment received | 11-Jul-22 07:49 |
Heads of Terms agreed for Sale of CD4 Business | 04-Jul-22 07:00 |